The Division conducts studies on the efficacy safety and cost-effectiveness of various antimalarial agents for the treatment of malaria in the country. Recently, various ACT combinations were evaluated with the view of advising appropriately what best combinations to be adapted under the current WHO directives on ACTs for the Clinical management of malaria in Nigeria. Studies on the molecular correlates of drugs-resistant P.falciparum in children in various Nigerian communities have also been carried out.
Other areas of research-focus of the Division are on the impact of nutrition on predominant infectious diseases in Nigeria. Studies have focused on the impact of various nutritional strategies in patients with HIV/AIDS, Tuberculosis and Malaria. The roles of micronutrients and antioxidants have also been studied.
In collaboration with other institutions, the Division is also carrying out studies on the antiprotozoal and anti-microbial properties of natural and synthetic organo-sulphur compounds.
The Division is also providing operational research support to the on-going roll back malaria programme in the country and is supported by the Global Fund, the Federal Ministry of Health and some Pharmaceutical companies.
The HOD co-supervises some staff in the Division who are registered for Ph.D programmes.
The units in the division are; Drug Analysis Unit, Nutrition Unit, Natural Products Unit, Malaria Molecular Biology Unit, and Operational Research Unit
